Anika Therapeutics | ANIK - Crediti Commerciali





Crediti Commerciali Cambiamento Data
Abbott USD 11.22B 655M 2026-03
Agenus USD 22.34M 107K 2026-03
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 8.56M 7.13M 2026-06
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Halozyme Therapeutics USD 453.33M 4.66M 2026-06
Heron Therapeutics USD 89.59M 8.54M 2025-12
Insmed USD 215.32M 36.77M 2026-06
Integra LifeSciences USD 267.19M 2.78M 2026-06
Intrexon USD 1.02M 559K 2024-06
J&J USD 22.54B 1.21B 2026-03
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
MacroGenics USD 10.42M 2.95M 2026-03
Merit Medical Systems USD 250.9M 23.9M 2026-06
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 492M 10M 2026-06
Smith & Nephew USD 1.52B 36M 2026-06
Stryker USD 3.74B 172M 2026-06
Veracyte USD 54.18M 4.06M 2026-06
Xencor USD 42.23M 30.23M 2026-06
Zimmer Biomet Holdings USD 1.77B 40.9M 2026-06